載入...
Failed, Interrupted, or Inconclusive Trials on Neuroprotective and Neuroregenerative Treatment Strategies in Multiple Sclerosis: Update 2015–2020
In the recent past, a plethora of drugs have been approved for the treatment of multiple sclerosis (MS). These therapeutics are mainly confined to immunomodulatory or immunosuppressive strategies but do not sufficiently address remyelination and neuroprotection. However, several neuroregenerative ag...
Na minha lista:
| 發表在: | Drugs |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Springer International Publishing
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8217012/ https://ncbi.nlm.nih.gov/pubmed/34086251 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40265-021-01526-w |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|